ASX:LCT Living Cell Technologies (LCT) Stock Price, News & Analysis → They said crypto was dead. It went up 100X. (From InvestorPlace) (Ad) Free LCT Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume76,622 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Living Cell Technologies alerts: Email Address Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. About Living Cell Technologies Stock (ASX:LCT)Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia.Read More Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. LCT Stock News HeadlinesMarch 12, 2024 | msn.comAutomated high-throughput sorting of living cells using laser light and AIMarch 11, 2024 | msn.comResearch team develops new technique to release and study individual proteins in cellsMarch 19, 2024 | Crypto 101 Media (Ad)Altcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… March 5, 2024 | msn.comResearchers demonstrate control of living cells with electronicsFebruary 22, 2024 | msn.comFirst-of-its-kind battery cell manufacturing facility coming to FargoFebruary 15, 2024 | msn.comProgramming cells to organize their molecules may open the door to new treatmentsJanuary 18, 2024 | msn.comNew technique visualizes mechanical structure of the cell nucleus for the first timeJanuary 18, 2024 | msn.comNew technique provides an unprecedented view inside the cell's control centerMarch 19, 2024 | The Bull Report (Ad)The AI Bottleneck No One is Talking AboutRenewable energy is growing at an impressive speed - but not fast enough. This could be one of the greatest periods for the nuclear industry ever.December 14, 2023 | msn.comNew method tags cells with location coordinates for single-cell studiesDecember 14, 2023 | msn.comSimplifying the way cell proliferation is monitored in miceDecember 6, 2023 | msn.comStartup gives new life to old technology — how a $109 million investment could help change the battery industryOctober 16, 2023 | news.yahoo.com40th anniversary of the first commercial cell phone callSeptember 26, 2023 | businesswire.comRed Cell Partners Launches Savoy Life, a Virtual Healthcare Platform for Long-Term CareSeptember 13, 2023 | uk.finance.yahoo.comLiving Cell Technologies Limited (LVCLF)September 1, 2023 | finance.yahoo.comLiving Cell Technologies Full Year 2023 Earnings: AU$0.002 loss per share (vs AU$0.002 loss in FY 2022)August 24, 2023 | msn.comCellares secures $255m for cell therapy development facilityAugust 23, 2023 | bizjournals.comSouth San Francisco cell therapy startup raises $255 millionAugust 11, 2023 | msn.com'From One Cell' Review: Blueprints for BuildingJuly 13, 2023 | technews.tmcnet.com3D Cell Culture Market worth $2.5 billion | MarketsandMarketsJuly 6, 2023 | msn.comThe Simplest Synthetic Cells Have Been Seen Evolving Faster Than Natural OnesJune 27, 2023 | technews.tmcnet.comCambrian Bio Launches Telos Biotech to Enable More Robust Cell TherapiesApril 30, 2023 | msn.comStanford Scientists Use Stem Cells to 3D-Print Heart TissueApril 8, 2023 | msn.comSMART LIVING: Cell phone safetyMarch 11, 2023 | msn.comIt’s a great time to start playing Dead CellsMarch 10, 2023 | msn.comWhat is the smallest unit of life? Get to know what makes up all living things.March 3, 2023 | marketwatch.comThe Cell Therapy Technologies study examines a number of direct and indirect factors that could affect the supply and demand dynamics in this marketSee More Headlines Receive LCT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Living Cell Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/19/2019Today3/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:LCT CUSIPN/A CIKN/A Webwww.lctglobal.com Phone61 3 8689 9997FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-54.06% Return on Assets-18.67% Debt Debt-to-Equity Ratio10.03 Current Ratio9.35 Quick Ratio17.84 Sales & Book Value Annual Sales$3,405.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.17 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,640,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.48 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. David Richard Hainsworth (Age 50)CEO & Exec. Chairman Comp: $40kMr. Daya UkaChief Financial OfficerDr. Belinda Di BartoloChief Operations OfficerDr. Carolyn M. Sue A.M. (Age 60)B.S., Ph.D., Member of Medical Advisory Board & Chief Medical Officer of NTCELL Comp: $50kMr. Madhukar Bhalla FCIS (Age 64)Company Sec. Comp: $40kDr. James A. MckennaChief Scientific OfficerMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersCarolyn SueSold 125,000 sharesTotal: $1,000.00 ($0.01/share) LCT Stock Analysis - Frequently Asked Questions How were Living Cell Technologies' earnings last quarter? Living Cell Technologies Limited (ASX:LCT) released its quarterly earnings data on Tuesday, February, 19th. The company reported $0.00 earnings per share for the quarter. What other stocks do shareholders of Living Cell Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Living Cell Technologies investors own include eWellness Healthcare (EWLL), Energous (WATT), AllianceBernstein Global High Income Fund (AWF). This page (ASX:LCT) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Living Cell Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.